Priority Date: 16.03.12 (US 201261611950P)

Histidine engineered light chain antibodies and genetically modified non-human animals for generating the same

  • Application ID: EP15151655
  • Status: EXAMINATION IN PROGRESS

Applicant

Technology company logo small
Technology Company

Attorney

no operation time available
1113.55
Headquarter in London and 4 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This patent has the IPC combination A01, C07, and C12 J A Kemp is specialized in the combination A01, C07, and C12. We found, that Isenbruck Bösl Hörschler LLP, Uexküll & Stolberg Partnerschaft von Patent- und Rechtsanwälten mbB, dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB, Weickmann & Weickmann PartmbB, Vereenigde Octrooibureaux NV (V.O.) and 30 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 16.03.2012 - Priority Date (US 201261611950P)
  • 17.06.2015 - Publication A1 (EP2883449)

IPC Classification